野村发布亚洲早间观点汇编，汇总全球市场研究。韩国方面，将Hanwha Systems评级由中性下调至减持，目标价6.0万韩元，因其向韩华航空航天出售费城造船厂股权后MASGA主题估值消退；韩国国防与工业调研显示韩华航空航天获选美国SPH原型供应商。印尼数据中心处成长初期，首次覆盖Total Bangun Persada给予买入，维持Indosat与Sarana Menara Nusantara买入。中国医疗：美国拟放宽对华许可交易，1H26中国对外授权达81笔、总额1100亿美元；医药十五五规划强调创新与全球化，目标研发/销售比超10%。中国科技：首次覆盖全志科技（买入，目标价39.30元）；亿纬锂能与Fluence签署2027-31年合计206GWh供货框架协议；首次覆盖伟星股份（买入）、周大生（中性）。亚洲出口领先指标NELI 10月回升至123.3，为2010年4月以来最强。
Nomura's Morning News & Views - Asia compiles select global markets research. In Korea, Hanwha Systems is downgraded to Reduce from Neutral with TP cut to KRW60,000, as the MASGA thematic value fades after its sale of the Hanwha Philly Shipyard stake to Hanwha Aerospace. A Korea Defense/Industrials tour noted Hanwha Aerospace was selected as the sole prototype contractor for the US SPH program. Indonesia's data center market is in the early innings of growth; coverage of Total Bangun Persada is initiated at Buy, while Buy ratings on Indosat and Sarana Menara Nusantara are maintained. On China healthcare, the US Treasury is developing rules to permit in-licensing deals with Chinese counterparts, with a record-high 81 out-licensing transactions worth USD110bn in 1H26; the 15th Five-Year Plan highlights innovation and globalization. In China tech, Allwinner Technology is initiated at Buy with TP CNY39.30; EVE Energy signed a 206GWh battery supply framework with Fluence for 2027-31;